Anthem Bioscienc

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0CZ201020
  • NSEID: ANTHEM
  • BSEID: 544449
INR
774.00
-13.1 (-1.66%)
BSENSE

May 20

BSE+NSE Vol: 19.48 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
610.94
423.15
550.03
540.21
483.20
497.81
524.96
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
610.94
423.15
550.03
540.21
483.20
497.81
524.96
Raw Material Cost
165.20
184.92
201.26
162.21
183.56
255.13
223.47
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
50.25
-42.33
22.10
68.67
-6.72
-22.42
-35.63
Employee Cost
72.48
70.48
67.72
72.03
59.78
56.87
96.39
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.01
0.00
0.00
0.00
0.01
0.00
0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
55.79
52.89
41.04
45.80
51.38
48.72
45.49
Total Expenditure (Excl Depreciation)
343.73
265.96
332.12
348.71
288.01
338.30
329.73
Operating Profit (PBDIT) excl Other Income
267.21
157.19
217.91
191.50
195.19
159.51
195.23
Other Income
51.21
33.53
48.23
22.81
14.06
24.37
27.85
Operating Profit (PBDIT)
318.42
190.72
266.14
214.31
209.25
183.88
223.08
Interest
1.90
0.35
3.03
1.61
0.52
2.55
3.55
Exceptional Items
0.98
-25.37
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
317.50
165.00
263.11
212.70
208.73
181.33
219.53
Depreciation
39.59
34.53
33.50
26.45
30.42
20.28
19.99
Profit Before Tax
277.92
130.47
229.60
186.25
178.31
161.05
199.53
Tax
88.16
37.66
56.17
50.46
95.69
36.72
37.61
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
189.76
92.82
173.43
135.79
82.62
124.33
161.93
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
189.76
92.82
173.43
135.79
82.62
124.33
161.93
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
189.76
92.82
173.43
135.79
82.62
124.33
161.93
Equity Capital
112.34
112.32
112.32
112.32
111.82
111.82
112.32
Face Value
2.0
2.0
2.0
2.0
2.0
2.0
2.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
3.38
1.65
3.09
2.42
1.48
2.22
2.88
Diluted Earnings per share
3.34
1.64
3.09
2.42
1.47
2.21
2.84
Operating Profit Margin (Excl OI)
43.74%
37.15%
39.62%
35.45%
40.4%
32.04%
37.19%
Gross Profit Margin
51.97%
38.99%
47.84%
39.37%
43.2%
36.43%
41.82%
PAT Margin
31.06%
21.94%
31.53%
25.14%
17.1%
24.98%
30.85%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is 39.83% vs -24.56% in Dec 2025

stock-summary

Standalone Net Profit

QoQ Growth in quarter ended Mar 2026 is 88.79% vs -43.50% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is 63.75% vs -27.75% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is 39.82% vs -49.33% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

Compare Quarterly Results Of Anthem Bioscienc With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
610.94
0
610.94
Other Operating Income
0.00
0.00
0.00
Total Operating income
610.94
0
610.94
Raw Material Cost
165.20
0
165.20
Purchase of Finished goods
0.00
0
0.00
(Increase) / Decrease In Stocks
50.25
0
50.25
Employee Cost
72.48
0
72.48
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.01
0
0.01
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
55.79
0.00
55.79
Total Expenditure (Excl Depreciation)
343.73
0
343.73
Operating Profit (PBDIT) excl Other Income
267.21
0.00
267.21
Other Income
51.21
0
51.21
Operating Profit (PBDIT)
318.42
0
318.42
Interest
1.90
0
1.90
Exceptional Items
0.98
0
0.98
Gross Profit (PBDT)
317.50
0
317.50
Depreciation
39.59
0
39.59
Profit Before Tax
277.92
0
277.92
Tax
88.16
0
88.16
Provisions and contingencies
0.00
0
0.00
Profit After Tax
189.76
0
189.76
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
189.76
0
189.76
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
189.76
0
189.76
Equity Capital
112.34
0
112.34
Face Value
2.00
0
0.00
Reserves
0.00
0
0.00
Earnings per share (EPS)
3.38
0
3.38
Diluted Earnings per share
3.34
0
3.34
Operating Profit Margin (Excl OI)
43.74%
0%
0.00
43.74%
Gross Profit Margin
51.97%
0%
0.00
51.97%
PAT Margin
31.06%
0%
0.00
31.06%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 582.50 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 39.83% vs -24.56% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 21.61%

Quarterly - Standalone Net Profit
Standalone Net Profit 211.67 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 88.79% vs -43.50% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 72.71%

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 266.99 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 63.75% vs -27.75% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 34.77%

Quarterly - Interest
Interest 1.58 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 39.82% vs -49.33% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -24.76%

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 45.84%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025